Bacteremia and sepsis

Emergency Medicine Clinics of North America

Volumn 14, Issue 1, 1996, Pages 185-195

  Ferguson, K L ^a   Brown, L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTEREMIA; CLINICAL OBSERVATION; EMERGENCY HEALTH SERVICE; HUMAN; INFECTION RISK; MONITORING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; TREATMENT PLANNING;

EID: 0030063861     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(05)70244-3     Document Type: Article

References (36)

1. M.E. Astiz E.C. Rackow J.L. Falk Oxygen delivery and consumption in patients with hyperdynamic septic shock Crit Care Med 15 1987 26 28
2. M.E. Astiz E.C. Rackow B. Laifam Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction Crit Care Med 16 1988 655 658
3. M.E. Astiz E. Tilly E.C. Rackow Peripheral vascular tone in sepsis Chest 99 1991 1072 1075
4. J. Bakker M. Coffernils M. Leon Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock Chest 99 1991 956 962
5. F. Bauss W. Droge D.N. Mannel Tumor necrosis factor mediates endotoxic effects in mice Infect Immun 55 1987 1622
6. R. Bone Gram-negative sepsis Chest 100 1991 802 808
7. R.C. Bone R.A. Balk F.B. Cerra ACCP/SCCM Consensus Conference Chest 101 1992 1644 1655
8. R. Bone C. Fischer T.P. Clemmer Sepsis syndrome: A valid clinical entity Crit Care Med 17 1989 389 393
9. B. Buetler N. Krochin I.W. Milsark Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance Science 232 1986 977
10. B.A. Buetler I.W. Milsark A. Cerami Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo J Immunol 135 1985 3972
11. B. Beutler I.W. Milsark A. Cerami Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin Science 229 1985 869
12. K.L. Brigham B. Meyrick Endotoxin and lung injury Am Rev Respir Dis 133 1986 913 927
13. D. Caput B. Beutler K. Hartog Identification of a common nucleotide sequence in the 3'-untranslated region of m-RNA molecules specifying inflammatory mediators Proc Natl Acad Sci USA 83 1986 1670
14. G. Carroll J. Synder Hyperdynamic severe intravascular sepsis depends on fluid administration in cyonomolgus monkey Am J Physiol 243 1982 R131 R141
15. L. Chelluri M.S. Jastremski Inadequacy of standard aminoglycoside loading doses in acutely ill patients Crit Care Med 15 1987 1143 1145
16. R.L. Danner A.F. Suffredini C. Watanason Microbial toxins: Role in the pathogenesis of septic shock and multiple failure Bihari D. Cerra F. New Horizons: Multiple Organ Failure 1989 Society of Critical Care Medicine Fullerton, CA 151 191
17. P. Desjars M. Pinaud G. Potel A reappraisal of norepinephrine therapy in human septic shock Crit Care Med 15 1987 134 137
18. D. Edwards C. Brown P. Nightengale Use of survivors cardiorespiratory values as therapeutic goals in septic shock Crit Care Med 17 1989 1098 1102
19. J.L. Falk E.C. Rackow J. Leavy Delayed lactate clearance in patients surviving circulatory shock Acute Care 11 1985 212 215
20. D.L. Fast Schlievert R.D. Nelson Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production Infect Immunol 57 1989 294 298
21. R.E. From A.F. Suffredini J.A. Kovacs Circulating tumor necrosis factor in normal volunteers receiving endotoxin Crit Care Med 16 1988 397
22. M.T. Haupt E.M. Gilbert R.W. Carlson Fluid loading increases oxygen consumption in septic patients with lactic acidosis Am Rev Respir Dis 131 1985 912 916
23. S. Jafri S. Lavine B. Field Left ventricular diastolic function in sepsis Crit Care Med 18 1990 709 714
24. S. Kaufman E.C. Rackow J.L. Falk The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock Chest 8 1984 336 340
25. I.C. Kettelhut W. Fiers A.L. Goldberg The toxic effects of tumor necrosis factor in vivo and their prevention bycyclooxygenase inhibitors Proc Natl Acad Sci USA 84 1987 4273
26. C. Martin B. Eon P. Saux Renal effects of norepinephrine used to treat septic shock patients Crit Care Med 18 1990 282 285
27. F.P. Ognibene M.M. Parker C. Natanson Depressed left ventricular performance: Response to volume infusion of patients with sepsis and septic shock Chest 93 1988 903 910
28. M.M. Parker J. Shelhamer C. Natanson Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate, an early predictor of prognosis Crit Care Med 15 1987 923 929
29. E.C. Rackow M.E. Astiz Mechanisms and management of septic shock Crit Care Clin 9 1993 219 237
30. E.C. Rackow B.S. Kaufman J.L. Falk Hemodynamic response to fluid repletion in patients with septic shock: Evidence for early depression of cardiac performance Circ Shock 22 1987 11 22
31. D.G. Remick R.G. Kunkel J.W. Larrick Acute in vivo effects of human recombinant tumor necrosis factor Lab Invest 56 1987 583
32. S.Q. Simpson L.C. Casey Role of tumor necrosis factor in sepsis and acute lung injury Crit Care Clin 5 1989 27 47
33. K.J. Tracey B. Beutler S.F. Lwory Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470
34. K.J. Tracey Y. Fong E.G. Hesse Anti-cachetin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia Nature 300 1987 662
35. J. Tuchschmidt J. Fried M. Astiz Elevation of cardiac output and oxygen delivery improves outcome in septic shock Chest 102 1992 216 220
36. A. Waage T. Espevik J. Lamvik Detection of tumor necrosis factor-like cytotoxicity in serum from patients with septicemia but not from untreated cancer patients Scand J Immunol 24 1986 739